Distribution of single nucleotide polymorphisms related to paclitaxel and carboplatin toxicity in ovarian cancer patients

被引：0
|
作者：
Cordova, Miguel
Bravo, Maria L.
Arriagada, Isidora
Cumsille, Elisa
Quinones, Luis
Bravo, Erasmo
Correa, Raimundo
Leiva, Juan E.
Paredes, Cesar
Cuello, Mauricio
Ibanez, Carolina
Garrido, Marcelo
Owen, Gareth I.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5031
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Response to and toxicity of weekly paclitaxel and carboplatin in patients with stage IIIC-IV ovarian cancer and poor general condition
    Takahashi, Suzuyo
    Takei, Yuji
    Tamura, Kohei
    Taneichi, Akiyo
    Takahashi, Yoshifumi
    Yoshiba, Takahiro
    Koyanagi, Takahiro
    Narumi, Risa
    Saga, Yasushi
    Fujiwara, Hiroyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (01)
  • [22] Is carboplatin-paclitaxel combination the standard treatment of elderly ovarian cancer patients?
    Zola, P.
    Ferrero, A.
    ANNALS OF ONCOLOGY, 2007, 18 (02) : 213 - 214
  • [23] Pharmacokinetic and pharmacodynamic analysis of combined chemotherapy with carboplatin and paclitaxel for patients with ovarian cancer
    Arakawa A.
    Nishikawa H.
    Suzumori K.
    Kato N.
    International Journal of Clinical Oncology, 2001, 6 (5) : 248 - 252
  • [24] The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
    Xia Wu
    Qin-Mei Feng
    Ying Wang
    Jun Shi
    Hai-Liang Ge
    Wen Di
    Cancer Immunology, Immunotherapy, 2010, 59 : 279 - 291
  • [25] Carboplatin and paclitaxel in patients with advanced ovarian cancer: A dose-finding study
    Huinink, WT
    Veenhof, C
    Huizing, M
    Rodenhuis, S
    Helmerhorst, T
    Dubbelman, R
    Dalesio, O
    Beijnen, J
    Winograd, B
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S31 - S33
  • [26] A phase II study of alternating paclitaxel and carboplatin in patients with advanced ovarian cancer
    Adams, M
    Mort, D
    Coleman, R
    Wiliams, L
    Evans, A
    Thompson, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 496 - 496
  • [27] The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer
    Dermitzakis, Emmanouil V.
    Kimiskidis, Vasilios K.
    Lazaridis, George
    Alexopoulou, Zoi
    Timotheadou, Eleni
    Papanikolaou, Alexandros
    Romanidou, Ourania
    Georgiadis, George
    Kalogeras, Konstantine T.
    Tsiptsios, Iakovos
    Tarlatzis, Basil
    Fountzilas, George
    BMC NEUROLOGY, 2016, 16
  • [28] A feasibility study of paclitaxel and carboplatin therapy in Japanese patients with epithelial ovarian cancer
    Takei, Y
    Suzuki, M
    Ohwada, M
    Saga, Y
    Kohno, T
    Machida, S
    Sato, I
    ONCOLOGY REPORTS, 2003, 10 (04) : 951 - 955
  • [29] A phase I/II study of carboplatin and paclitaxel in patients with epithelial ovarian cancer
    Yamamoto, R
    Minobe, S
    Kaneuchi, M
    Sakuragi, N
    Fujimoto, S
    Ishizaki, Y
    Domon, H
    Hareyama, H
    Sato, C
    Fujino, T
    Kawaguchi, I
    Yamaguchi, T
    Fujimoto, T
    Yoshiaki, K
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (04) : 128 - 134
  • [30] The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
    Wu, Xia
    Feng, Qin-Mei
    Wang, Ying
    Shi, Jun
    Ge, Hai-Liang
    Di, Wen
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (02) : 279 - 291
12345